Posted in | News | Solar Energy | Nanotechnology

Shrink Nanotechnologies Files Novel Patent Applications on Solar Concentrator Technology

Shrink Nanotechnologies, Inc. has filed novel patent applications on the company’s solar concentrator technology. Shrink Nanotechnologies licenses opportunities and develops products in the solar power generation; biotechnology and sensors R&D tools; and medical diagnostics businesses.

Shrink Nanotechnologies has sole rights to commercialize and develop products based on Quantum Dot Solar Concentrator, a patent-pending technology that enhances currently available photovoltaic (PV) systems based on silicon as well as the capability of these systems to efficiently generate electricity from sunlight.

Shrink Nanotechnologies’ CEO Mark L. Baum stated that going forward even as countries such as the U.S., India and China among others consume every quantity of power that can be produced which includes oil, coal, natural gas, biofuels, tide, wind and solar, the role of clean energy will be crucial in the future. To this end, the company’s patent applications and solar technologies will help produce renewable and clean energy.

Quantum dot-polymer materials and other quantum dot impregnated materials are capable of increasing the power produced from conventional solar cells. Such silicon-based systems are likely to be customized to provide maximum output. In the near future, Shrink Nanotechnologies hopes to roll out advanced, non-optical, ultra-functional solar concentrators into the market.

The Scientific Founder of Shrink Nanotechnologies Michelle Khine stated that currently the electric power production system in the U.S. has around 1,000 GW of production capacity; however, solar power is under-used to a large extent. If every U.S. home had installed a 3 kW rooftop system, over 35% of overall residential energy needs can be met. To this end, the company’s quantum dot solar concentrator can help accelerate usage and adoption of solar energy.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.